Wassana Yantasee, the PDX Pharmaceuticals’ President was inducted into the Council of Outstanding Early Career Engineers, 2014 Oregon Stater Award.
pdx news
PDX Pharma awarded two-year $1.87M phase II SBIR grant from the National Cancer Institute (NCI) for the development of ARAC-02, a novel lung cancer treatment